América Latina Investiga Covid-19

COVI19 Informes chequeados Informes científicos chequeados América Latina Investiga

COVID-19

Informes Científicos CHEQUEADOS

América Latina Investiga

Artículos recientes publicados por colecciones de revistas científicas biomédicas de América Latina.
La información se presenta en castellano, portugués o inglés, según fuera publicada por los editores o registrada en las bases de datos.
La mayoría de los artículos enlaza con los textos completos y gratuitos de las revistas.
Los trabajos fueron provistos por sus editores o seleccionados por SIIC en recursos documentarios de la región: Scielo, Lilacs, BVS, WHO Iris, Lis, PAHO Iris, SIIC Data Bases y otros.

SPECIAL ARTICLE COVID-19: Covid-19-Related Acute Invasive Fungal Sinusitis: Clinical Features and Outcomes

Abdelsamie, Alaa Mohamed; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG, Abdelazim, Hossam Mohamed; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG, Leer más

Elnems, Mohamed Goda; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG, Abdelhakam, Rehab Bassam; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG, Abdelalim, Abdelrahman Ahmed; Benha University. Otorhinolaryngology department. Faculty of Medicine. Benha. EG

Fuente científica: Int. arch. otorhinolaryngol. (Impr.)

Fecha de actualización: 6 Abril, 2022

Abstract Introduction There is a noticeable increase in the incidence of acute invasive fungal sinusitis which coincides with the ongoing coronavirus pandemic. It is a potentiallylethal fungal infection, with the most common form being the rhino-orbito-cerebral presentation. Objectives The aim of the present study is to discuss the different epidemiological factors, risk factors, clinical presentations and outcomes of acute invasive fungal sinusitis which is noticeably related to the coronavirus disease 2019 (Covid-19) pandemic. Methods The present cross-sectional cohort study included 22 adult patients who presented with Covid-19-related acute invasive fungal sinusitis. The diagnosis of acute invasive fungal sinusitis was confirmed by histopathological biopsy. All data, including demographics, risk factors, clinical findings, different lines of treatment and their outcomes, were recorded and analyzed. Results All patients had diabetes mellitus (100%), and 17 (77.3%) had been submitted to systemic steroids. All patients (100%) had unilateral sinonasal disease. Proptosis was found in 15 patients (68.2%), ophthalmoplegia was observed in 12 patients (54.5%), and intracranial affection occurred in 10 patients (45.5%). A total of 20 patients (90.9%) received liposomal amphotericin B. Surgical debridement was performed in 18 patients (45.5%). Non-septated mycelia was present in 19 biopsies (86.4%), while 3 (13.6%) showed septated mycelia. Total improvement was achieved in 10 patients (45.5%), while the mortality rate was of 27.3% (6 out of 22 participants). Conclusion Diabetes mellitus is the most common preexisting medical condition associated with Covid-19-related acute invasive fungal sinusitis. Systemic corticosteroid therapy is considered a predisposing factor. It is necessary to raise the level of awareness to diagnose this condition, especially in patients with Covid-19 infection or those who have recently recovered from it.

Palabras clave: Covid-19, Mucormycosis, Sinusitis

Dependências e saúde mental na era trans e pós-COVID-19: estamos preparados para ensinar e tratar?
Addictions and mental health in the trans- and post-COVID-19 era: are we prepared to teach and treat?

Pechansky, Flavio; Hospital de Clínicas of Porto Alegre. Addiction Psychiatry Service. BR, Sordi, Anne; Hospital de Clínicas of Porto Alegre. Addiction Psychiatry Service. BR, Leer más

Benzano, Daniela; Hospital de Clínicas of Porto Alegre. Center for Drug and Alcohol Research. BR, Ornell, Felipe; Hospital de Clínicas of Porto Alegre. Center for Drug and Alcohol Research. BR

Fuente científica: Jornal Brasileiro de Psiquiatria

Fecha de actualización: 6 Abril, 2022

"Pegar" ou "passar ": medos entre profissionais da linha de frente da COVID-19
"To Catch" or "to give": fears among frontline professionals at COVID-19

Horta, Rogerio Lessa; Universidade Feevale. Novo Hamburgo. BR, Lucini, Thaís Caroline Guedes; Universidade Feevale. Novo Hamburgo. BR, Leer más

Lantin, Pedro José Sartorelli; Universidade Feevale. Novo Hamburgo. BR, Perdonssini, Laura de Brizola; Universidade Feevale. Novo Hamburgo. BR, Sette, Talia Greici; Universidade Feevale. Novo Hamburgo. BR, Bittencourt, Michele Cristina; Universidade Feevale. Novo Hamburgo. BR, Barbosa, Marcus Levi Lopes; Universidade Feevale. Novo Hamburgo. BR, Camargo, Eduardo Guimarães; Universidade Feevale. Novo Hamburgo. BR

Fuente científica: Jornal Brasileiro de Psiquiatria

Fecha de actualización: 6 Abril, 2022

RESUMO Objetivo: Investigar a relação entre a realização de testes para detectar COVID-19 e indícios de sofrimento psíquico, estresse e burnout entre profissionais de saúde da linha de frente da pandemia em um hospital geral. Métodos: Estudo prospectivo de abordagem mista usando SRQ-20, PSS, OBI e entrevistas em profundidade em série de três entrevistas em 2020. Resultados: Prevalências preocupantes de escores elevados de SRQ20, Burnout e Estresse Percebido ocorreram nas três entrevistas, e o registro de testes realizados foi crescente no período estudado, mas não houve associação entre desfechos e realização de testes para detectar COVID-19. Os temores de contrair a doença e de ser transmissor do vírus apareceram como os principais estressores para profissionais de saúde, mantidos apesar da realização de testes. Conclusões: Nesse grupo, testes realizados não se mostraram suficientes para modificar os efeitos psicossociais da atividade em linha de frente sobre profissionais de saúde.

ABSTRACT Objective: To investigate the relationship between the performance of tests to detect COVID-19 and signs of psychological distress, perceived stress and burnout among health professionals on the frontline of the pandemic in a general hospital. Methods: Prospective mixed-approach study using SRQ-20, PSS, OBI and in-depth interviews in a series of 3 interviews throughout 2020. Results: Worrying prevalences of high scores of SRQ20, Burnout and Perceived Stress occurred on the three interviews and the number of tests performed increased during the study period, but there was no association between outcomes and testing to detect COVID- 19. Fear of contracting the disease or being a transmitter of the virus appeared as the main stressors for health professionals, maintained despite testing. Conclusions: In this group, tests performed were not sufficient to modify the psychosocial effects of the front line activity on health professionals.

Palabras clave: Burnout, Burnout, COVID-19 testing, COVID-19, COVID-19, Emotional stress, Estresse emocional, Health professionals, Profissionais de saúde, Teste COVID-19

Reabilitação pós-COVID-19: demandas dos pacientes e resultado da intervenção por equipe multidisciplinar
Recovery after covid-19: treatment program in an integrated rehabilitation center

Crema, Chiara Maria Tha; Hospital Angelina Caron. Campina Grande do Sul. BR, Hummelgen, Eduardo; Hospital Angelina Caron. Campina Grande do Sul. BR, Leer más

Demogalski, Luana Cristina Basso; Hospital Angelina Caron. Campina Grande do Sul. BR, Cardoso, Luma; Hospital Angelina Caron. Campina Grande do Sul. BR, Bauer, Claudia; Hospital Angelina Caron. Campina Grande do Sul. BR, Nickel, Renato; Universidade Federal do Paraná. Curitiba. BR

Fuente científica: Acta fisiátrica

Fecha de actualización: 5 Abril, 2022

Apesar de atingirem padrões de alta clínica, pacientes com COVID-19 não retomam as atividades cotidianas devido à incapacidade, sendo o processo de reabilitação de interesse dos serviços de saúde e sociedade. Objetivos:Descrever o nível de funcionalidade do paciente pós-COVID-19 e resultados de um processo de reabilitação multidisciplinar.Métodos: Estudo observacional, descritivo, de abordagem quantitativa, relativo à avaliação das demandas e processo de reabilitação interdisciplinar. Resultados: 22 pacientes participaram do estudo, idade 48,46 anos (±12,63), 50% homens, sendo que 81,8% apresentavam comorbidades e 95,5% sobrepeso ou algum grau de obesidade. Todos apresentaram diminuição na QV (SF36) e não alcançaram a distância média esperada para o teste de 6 minutos, 20 pacientes apresentaram dispnéia para realizar as atividades cotidianas e 21 apresentaram limitação na Escala de Status Funcional pós-COVID-19 (PCSF). O resultado do processo de reabilitação com 20 pacientes, mostrou na comparação antes e depois, diferenças significativas na força muscular (,000) PeakFlow Meter (,000), Berg (,000), Barthel (,001), teste 6 minutos para freqüência cardíaca (,002) e distância percorrida (,000). Na SF-36 para os domínios de Estado Geral da Saúde (,058) e Aspectos Emocionais (,194) a diferença não foi significativa. Para as variáveis ordinais houve diferença significativa para PCSF (,000) e dispnéia (,000).Conclusão: O estudo aponta que a incapacidade do paciente teve maior correlação na entrada do serviço com o tempo de internação e que um processo de reabilitação interdisciplinar melhora na funcionalidade e QV do paciente com sequelas de COVID-19.

Despite reaching clinical discharge standards, patients with COVID-19 do not resume daily activities due to disability, and the rehabilitation process is of interest to health services and society. Objectives:To describe the post-COVID-19 patient's level of functionality and the result of a multidisciplinary rehabilitation process. Methods:observational, descriptive study, with a quantitative approach, related to the assessment of demands and interdisciplinary rehabilitation process. Results:22 patients participated in the study, age 48.46 years (±12.63), 50% were men, 81.8% had comorbidities and 95.5% were overweight or had some degree of obesity. All of them had a decrease in QoL (SF36) and did not reach the average distance expected for the 6-minute test, 20 patients had dyspnea to perform daily activities and 21 had limitations on the Post-Covid Functional Status Scale(PCSF). The result of the rehabilitation process with 20 patients, showed in the comparison before and after, significant differences in muscle strength (.000) Peak Flow Meter (.000), Berg (.000), Barthel (.001), 6-minute test for heart rate (.002) and distance traveled (.000). In the SF-36 for the General Health Status (.058) and Emotional Aspects (.194) domains, the difference was not significant. For the ordinal variables, there was a significant difference for post-COVID-19 Functional Status Scale (PCFS)(.000) and dyspnea (.000). Conclusion:The study points out that the patient's disability had a greater correlation at the entrance of the service with the length of hospitalization and that an interdisciplinary rehabilitation process improves the functionality and QOL of the patient with sequelae of COVID-19.

Palabras clave: COVID-19, COVID-19, Modalidades de Fisioterapia, Occupational Therapy, Physical Therapy Modalities, Rehabilitation Services, Serviços de Reabilitação, Terapia Ocupacional

Impacto de la edad gestacional en la gravedad de la infección por Sars-CoV-2 en personas gestantes, en un hospital del conurbano bonaerense
Impact of gestational age on the severity of Sars-CoV-2 infection in pregnant people, in a hospital in the Buenos Aires surroundings

Guzzi, Leda; Hospital Maternidad Santa Rosa. Ciudad Autónoma de Buenos Aires. AR, Udry, Sebastián; Hospital Maternidad Santa Rosa. Ciudad Autónoma de Buenos Aires. AR, Leer más

Bolardi, Rocío; Hospital Maternidad Santa Rosa. Ciudad Autónoma de Buenos Aires. AR, Matera, Miriam; Hospital Maternidad Santa Rosa. Ciudad Autónoma de Buenos Aires. AR, Sánchez, Adriana; Hospital Maternidad Santa Rosa. Ciudad Autónoma de Buenos Aires. AR, Rodríguez, María Raquel; Hospital Maternidad Santa Rosa. Ciudad Autónoma de Buenos Aires. AR, Longueira, Yésica; Universidad de Buenos Aires. CONICET. Instituto de Investigaciones Biomédicas en Retrovirus y SIDA. Ciudad Autónoma de Buenos Aires. AR, Turk, Gabriela; Universidad de Buenos Aires. CONICET. Instituto de Investigaciones Biomédicas en Retrovirus y SIDA. Ciudad Autónoma de Buenos Aires. AR, Laufer, Natalia; Universidad de Buenos Aires. CONICET. Instituto de Investigaciones Biomédicas en Retrovirus y SIDA. Ciudad Autónoma de Buenos Aires. AR, Balbiano, Sergio; Hospital Maternidad Santa Rosa. Ciudad Autónoma de Buenos Aires. AR

Fuente científica: Actual. SIDA. infectol

Fecha de actualización: 5 Abril, 2022

ntroducción: La información sobre la evolución de la infección por COVID-19 en personas gestantes (PG) continúa en desarrollo.Objetivos: Describir la presentación de la infección por Sars-CoV-2 en PG y determinar variables asociadas a mayor gravedad.Materiales y métodos: Estudio observacional retrospectivo. Periodo: 01/03/2020-31/07/2021. Se incluyeron PG con diagnóstico de COVID-19 asistidas en una maternidad de gestión pública: se clasificaron según gravedad y se dividieron en dos grupos: Grup o1 leve y de manejo ambulatorio; Grupo 2 moderado, severo y crítico, con internación. Se analizó la relación entre gravedad y obesidad, DBT, hipertensión inducida por el embarazo (HIE), edad gestacional, edad materna, vacunación antigripal. Recién nacidos (RN) de madres infectadas se estudiaron con PCR para Sars-CoV-2 24-48 hs postnacimiento. Análisis estadístico: Chi-cuadrado o test exacto de Fisher. Significancia= p<0,05. Aprobado porComité Ética Institucional.Resultados: 52 PG con diagnóstico de COVID-19. Edadmediana 29,6 años. Grupo 1: 29 PG (55,5%). Grupo 2: 23 PG(44%), 19 (36,5%) moderados, 2 (4%) severos y 2 (4%) críticos. No hubo fallecimientos maternos ni fetales. Edad gestacional ≥ 28 semanas fue la única variable asociada a mayor gravedad,p=0,00004. 48% de los embarazos finalizaron por cesárea.48/52 RN fueron estudiados con PCR para Sars-CoV-2, siendo 1 (2%) positivo (fue el único RN sintomático).Conclusiones: La infección por COVID-19 en PG se asoció a presentaciones clínicas más graves cuando la infecciónse cursó en el tercer trimestre de gestación y se asociócon mayor incidencia de cesáreas

ntroduction: The information concerning the impact of COVID-19 infection in pregnant people (PP) continues to be established.Aim: to describe the evolution of the Sars-CoV-2 infection in pregnant people and to determine variables associated with clinical severity.Materials and Methods: Retrospective observational study. Period: 01-03-2020 to 31-07-2021. We included PP with diagnosis of COVID-19, assisted in a public maternity hospital. The cases were classified according to clinical severity based on the NIH guidelines. The patients were divided into 2 groups: Group 1: mild (ambulatory manage-ment). Group 2: moderate, severe and critical (requiring hospitalization). The relationship between variables and clinical severity was analyzed. Variables studied: obesity, DBT, gestational hypertension, gestational age, maternal age, influenza vaccination. Newborns of infected mothers were studied with PCR for Sars-CoV-2 24 to 48 hours af-ter birth. Statistical analysis: Chi-square or Fisher's exact test, significance = p <0.05. Study approved by the Institu-tional Ethics Committee.Results: 52 PP with diagnosis of COVID-19 were includ-ed. Median age 29.6 years. 23 patients (44%) required hospitalization and 2 (4%) MRA (mechanical respiratory assistance). 29 (55.5%) were mild, 19 (36.5%) moderate, 2 (4%) severe, and 2 (4%) critical. There were no mater-nal or fetal deaths. Gestational age ≥ 28 weeks was the only variable associated with more severe clinical forms, p = 0.0001. 48% of the pregnancies ended by cesarean section. 48/52 newborns were studied with PCR for Sars-CoV-2, with only 1 (2%) being positive. This was the only symptomatic newborn.Conclusions: In our study, Sars-CoV-2 infection during pregnancy was associated with more severe clinical pre-sentations when the infection occurred in the 3rd trimes-ter of pregnancy. COVID-19 was also associated with a higher incidence of ter

Palabras clave: COVI-19, Sars-CoV-2, edad gestacional, embarazadas, evolución, gestantes, severidad clínica.

Experiencias del personal de salud sobre la implementación de prácticas de protección contra COVID-19 en la Argentina
Experiences of protection against COVID-19

Danesi, Emmaría; Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias (CeNDIE). Ciudad Autónoma de Buenos Aires. AR, Maltz, Tatian Yael; Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias (CeNDIE). Ciudad Autónoma de Buenos Aires. AR, Leer más

Blanco, Josefina; Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias (CeNDIE). Ciudad Autónoma de Buenos Aires. AR, Peyrán, Pamela; Instituto Nacional de Parasitología "Dr. Mario Fatala-Chabén". Ciudad Autónoma de Buenos Aires. AR, Carbajal-De-La-Fuente, Ana Laura; Centro Nacional de Diagnóstico e Investigación en Endemo-Epidemias (CeNDIE). Ciudad Autónoma de Buenos Aires. AR, Fernández, Marisa Liliana; Instituto Nacional de Parasitología "Dr. Mario Fatala-Chabén". Ciudad Autónoma de Buenos Aires. AR

Fuente científica: Actual. SIDA. infectol

Fecha de actualización: 5 Abril, 2022

El objetivo de este estudio fue indagar sobre experiencias y percepciones del personal de salud (PDS) de la Argentina en la implementación de protocolos para su protección durante la pandemia por COVID-19. Se realizó una encuesta al PDS a nivel nacional, relevando datos sociodemográficos, de protocolos, recursos y aspectos psicosociales. Se analizaron 2010 encuestas. El 76,4% fueron mujeres, 43 años de edad media, 35% médicos/as y 72,7% del subsistema público. El 37,2% aumentó su carga horaria y el 22,5% presentaba algún factor de riesgo, de quienes 20,4% tuvo licencia o reasignación de tareas. Se establecieron protocolos sobre uso de equipos de protección personal (EPP) en 91% de las instituciones y otras temáticas en menor medida. La claridad de los mismos fue bien valorada y hubo entrenamiento en el 60,8% de los casos. La conformidad con la disponibilidad y calidad del EPP fue variable, con mejor valoración en el subsector privado. El 60,4% tuvo necesidad de obtener EPP por medios propios. El 48,4% de los encuestados siguió los protocolos de uso de EPP, variando según grupos de riesgo. El indicador global de valoración institucional fue 6,45/10 (IC 95% 6,38-6,53). El 87,2% del PDS dijo haber sentido angustia y esto se relacionó con peor comunicación con superiores y peor valoración institucional. De este estudio surgen dificultades en la implementación de los nuevos cuidados, y la necesidad de intensificar esfuerzos en recursos y organización institucional para mejorar las condiciones de trabajo.

During the COVID-19 pandemic, health personnel (HP) faced changes in their working conditions due to exposure to the virus and increased demand for attention. This study inquires on the experiences and perceptions of HP in Argentina about the implementation of protocols for their protection. A survey including information on sociodemographic characteristics, protocols, resources and psychological aspects was performed for HP all over the country. Two thousand and ten surveys were analyzed: 76.4% female, mean age 43 years old, 35% physician, 72.7% public institutions. Hours of work increased for 37.2%, 22.5% had at least one risk factor, of which 20.4% had leave or re-assigned tasks. Protocols about use of personal protective equipment (PPE) were established by 91% of institutions and less frequently about other topics. Clarity of protocols was well evaluated, and in 60.8% of cases trainament was performed. Approval about access and quality of PPE was variable, with better performance on private institutions. 60.4% of the HP had to obtain PPE by their own means. 48.4% of the participants followed protocols on PPE, being this variable according to groups of risk. The global index for institutional valuation was 6.45/10 (CI 95%, 6.38-6.53). HCP expressed fear or anxiety in 87.2% of the cases, and this was related to worse communication with superiors and worse institutional valuation. This study raises difficulties on the implementation of new protocols and the need to reinforce efforts on resources and institutional organization, to improve working conditions for HP

Palabras clave: Argentina, COVID-19, ambiente laboral, equipos de protección personal, personal de salud

Eficacia terapéutica y seguridad del tocilizumab en COVID-19
Therapeutic efficacy of tocilizumab in COVID-19

Di Líbero, Eugenia; Hospital Interzonal General de Agudos "Evita". Buenos Aires. AR, Osuna, Carolina; Hospital Zonal General de Agudos "A. Eurnekian". Buenos Aires. AR, Leer más

Gañete, Marcelo; Hospital Interzonal General de Agudos "Evita". Buenos Aires. AR

Fuente científica: Actual. SIDA. infectol

Fecha de actualización: 5 Abril, 2022

A la fecha, excepto los glucocorticoides, ningún otro tratamiento farmacológico ha demostrado disminución de la mortalidad en pacientes con COVID-19 grave-crítico. Con el objetivo de discutir su utilidad en la terapéutica, se realizó una revisión y lectura crítica de los estudios publicados más significativos sobre el uso de tocilizumab.Se llevó adelante una búsqueda en las principales bases de datos bibliográficas priorizando la inclusión de revisiones sistemáticas y ensayos clínicos aleatorizados controlados (ERC) que analizaran el efecto del tocilizumab en COVID-19 en diferentes puntos de valoración.Se incluyeron 5 ERC y 4 metaanálisis en la evaluación, todos ellos incluyeron pacientes con COVID-19 confirmado y mayoritariamente graves-críticos. El punto de valoración principal (PVP) fue la mortalidad a los 28 días y como resultado secundario de relevancia, la progresión a ventilación mecánica invasiva (VMI). Se analizó, además, la seguridad de la intervención, fundamentalmente a nivel de la ocurrencia de infecciones secundarias.Del análisis surge que la mayor posibilidad de beneficio parece estar circunscripta a pacientes con enfermedad grave-crítica, que reciben corticoides, con marcadores de inflamación elevados (PCR >10 mg/dL) y enfermedad rápidamente progresiva. Existe alto grado de certeza respecto del impacto del tocilizumab en evitar la progresión a VMI, con una pequeña magnitud del efecto y moderado grado de certeza respecto de su impacto en la mortalidad; además de que resultó una medicación segura

Up until now, other than corticosteroids, no other pharmacological treatment has shown a decrease in mortality rate in patients with severe-critical COVID-19. In order to discuss its place in therapy, a review and critical reading of the most significant published studies on the use of tocilizumab was carried out.Search was done in the main bibliographic databases, prioritizing the inclusion of systematic reviews and randomized controlled clinical trials (RCTs); that analyzed the effect of tocilizumab on COVID-19 at different endpoints.5 RCTs and 4 meta-analysis were considered in the evaluation, all of them including patients with confirmed COVID-19 and predominantly severe-critical illness. The primary endpoint was 28-day all-cause mortality and, as a secondary outcome of relevance, progression to invasive mechanical ventilation. The safety of the intervention was also analyzed, mainly the occurrence of secondary infections.From our analysis it appears that the greatest possibility of benefit seems to be limited to patients with severe-critical illness, who receive corticosteroids, with high markers of inflammation values (CRP> 10 mg/dL) and rapidly progressive disease. There is high certainty regarding the impact of tocilizumab in preventing progression to IMV, with a small effect size and moderate certainty regarding its impact on mortality. Moreover, it was a well-tolerated and safe medication

Palabras clave: COVID-19, Tocilizumab, tratamiento

¿Cambió la adherencia al lavado de manos en tiempos de SARS-CoV-2?
¿Did adherence to hand hygiene chance during SARS-CoV-2 pandemic?

Hinojosa, Mirian; Clínica Olivos. Servicio de Infectología y control de infecciones. Buenos Aires. AR, Guzzi, Leda; Clinica Olivos. Servicio de Infectología y control de infecciones. Buenos Aires. AR, Leer más

Camblor, Fabricio; Clinica Olivos. Servicio de Farmacia. Buenos Aires. AR, Cristin, Martin; Clinica Olivos. Servicio de Infectología y control de infecciones. Buenos Aires. AR

Fuente científica: Actual. SIDA. infectol

Fecha de actualización: 4 Abril, 2022

Objetivo principal: Determinar la adherencia al lavado de manos en el personal de salud en los periodos pre-pandemia y pandemia SARS-CoV-2. Objetivos secundarios: Determinar la adherencia según categoría profesional, sectores de internación y momentos del lavado de manos. Determinar el grado de cumplimiento según una escala de referencia. Metodología: Estudio cuasi experimental que evaluó la adherencia al lavado de manos antes y después de intensificar medidas de prevención. Se comparó la adherencia de dos períodos, diciembre 2019 y agosto 2020. Resultados: Se observó que la adherencia en 2019 fue 67% (IC95%: 63%-71%) y en 2020 de 89% (IC95%: 86%-92%), lo que implica un aumento de 22% (IC95%: 0.17-0.27; p:0.000). En el análisis de subgrupos de momentos de la OMS se observó un aumento en los momentos agrupados como antes (65,7 a 81,2; p:0.001) y como después (67,7 a 94,3; p:0.000). En el análisis por sectores de internación se observó un aumento en los sectores de guardia (50,5 a 100; p:0.000) e internación (63,3 a 78,0; p:0.006) y en pediatría (94,2 a 96,5; p:0.336) y UTI/UCO (63,7 a 70,5; p:0.405), en estos dos últimos no significativo. En el análisis por categoría profesional se observó un aumento en las categorías enfermero (81,4 a 92,9; p:0.001), médicos (66,7 a 83,8; p:0.003), técnicos (57,8 a 93,2; p:0.000) y apoyo (49,4 a 83,9; p:0.000). Discusión: En nuestro estudio, la intensificación de las medidas de lavado de manos y la pandemia motivaron un incremento significativo en la adherencia a la higiene de manos

Main objective. To determine the adherence to hand washing in health care staff in pre-pandemic and SARS-CoV-2 pandemic periods, after intensifying the measures of a program. Secondary objectives. Determine adherence according to professional category, hospitalization sectors and moments of hand washing. Methodology. Quasi-experimental study that evaluated adherence to hand washing before and after intensifying measures. The adherence of 2 periods was compared, December 2019 and August 2020. Outcomes. It was observed that adherence in 2019 was 67% (95% IC: 63% -71%) and in 2020 it was 89% (95% IC: 86% -92%), which implies an increase of 22% (95% IC: 0.17-0.27; p: 0.000). In the subgroup analysis of WHO moments, an increase was observed in the moments grouped as before (65.7 to 81.2; p: 0.001) and as after (67.7 to 94.3; p: 0.000). In the analysis by hospitalization sectors, an increase was observed in emergency sectors (50.5 to 100; p: 0.000) and hospitalization (63.3 to 78.0; p: 0.006) and not significant in pediatrics (94.2 to 96.5; p : 0.336) and UTI / UCO (63.7 to 70.5; p: 0.405). In the analysis by professional category, a significant increase was observed in the categories nurse (81.4 to 92.9; p: 0.001), doctors (66.7 to 83.8; p: 0.003), technicians (57.8 to 93.2; p: 0.000) and support (49.4 to 83.9; p: 0.000). Conclusion. In our study, the intensification of hand washing measures and the pandemic led to a significant increase in adherence to hand hygien

Palabras clave: Higiene de manos, adherencia lavado de manos, programa de adherencia lavado de manos

COVID-19, dos años y 458 millones de casos después
COVID-19, two years and 458 million cases later

Vedia, Lautaro de; Hospital Francisco J. Muñiz. Ciudad Autónoma de Buenos Aires. AR

Fuente científica: Actual. SIDA. infectol

Fecha de actualización: 4 Abril, 2022

Acerca de SIIC